Showing metabocard for Urdamycinone B (MMDBc0060825)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 2.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 23:39:19 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:24 UTC | ||||||||||||
| Metabolite ID | MMDBc0060825 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Urdamycinone B | ||||||||||||
| Description | Urdamycinone B is an angucycline glycoside, a chemical class characterized by a complex polycyclic structure that includes a naphthacene backbone. It is produced through specific biosynthetic gene clusters (BGCs), as revealed by mass spectral networking techniques that identified the co-production of urdamycinone B alongside other metabolites like aquayamycin and galtamycin C (PMID:36697563 ). The biosynthesis of urdamycinone B involves the action of several genes, where the inactivation of urdZ3, urdQ, and urdZ1 leads to the accumulation of urdamycinone B due to the blockage of L-rhodinose production (PMID:11094336 ). Additionally, urdamycinone B can be synthesized from aquayamycin, demonstrating its role as a downstream metabolite in the biosynthetic pathway (PMID:11026547 ). The production of urdamycinone B is sensitive to environmental conditions; specifically, it requires an alcohol-free medium to prevent its rearrangement into other compounds, such as naphthacenequinones (PMID:3583915 ). Overall, urdamycinone B exemplifies the intricate chemistry and biosynthetic pathways characteristic of angucycline glycosides. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C25H24O8 | ||||||||||||
| Average Mass | 452.459 | ||||||||||||
| Monoisotopic Mass | 452.147117733 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | RWSPXLDDWKEOIW-XDUBSXOCSA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Chromatographic Retention Times and Retention Indices | |||||||||||||
| Retention Times | Not Available | ||||||||||||
| Retention Indices | Not Available | ||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | Not Available | ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | RWSPXLDDWKEOIW-XDUBSXOCSA-N | ||||||||||||
| General References | |||||||||||||
| |||||||||||||
